The developmental layers in the CD8+ T cell response to chronic infection
The developmental layers in the CD8+ T cell response to chronic infection
批准号:
10216650
负责人:
ANDREW W GRIMSON
金额:
$47.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-03-01 至 2023-07-31
关键词:
AddressAdoptedAdultAdverse eventAntigensAwardB-LymphocytesBehaviorCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCellsChronicCuesDevelopmentEffector CellExhibitsExperimental ModelsFundingGenomic approachGoalsGrantHematopoietic stem cellsHeterogeneityImmuneImmune systemImmunityImmunotherapyImpairmentIndividualInfectionInflammationKineticsKnowledgeLifeLinkLymphocytic choriomeningitis virusMalignant NeoplasmsMemoryNaturePatientsPhenotypePopulationPositioning AttributePropertyPublishingRegulator GenesSystemT cell responseT memory cellT-Cell DevelopmentT-LymphocyteTherapeuticUp-RegulationVariantViralWorkacute infectionbasecell behaviorchronic infectionexhaustexhaustionfetalfunctional restorationimmune functionimmunopathologymonocytemouse modelnovelnovel strategiesoverexpressionpathogenpreventprogenitorprogramsreceptorstem cellsγδ T cells
中文摘要
项目摘要/摘要
感染后,一小部分效应性CD8+T细胞存活并过渡到长期记忆中
游泳池。鉴于记忆CD8+T细胞是免疫细胞内病原体的关键,我们有必要
了解它们的形成机制。这个问题一直是该领域的前沿问题
几十年。目前的教条表明,单一的幼稚T细胞谱系可以产生不同的短小和
长寿的效应器或记忆T细胞亚群,取决于它们遇到的信号(炎症、抗原)
在感染期间。然而,在上一个资金周期中,我们发现T细胞采用
相反,感染期间的特定命运是在感染之前预先编程的,并在很大程度上由它们的
发育起源。由于我们到目前为止的所有工作都是在急性感染的情况下进行的,主要的
我们更新提案的目标是将我们的研究扩展到慢性感染,在那里我们将确定如何
记忆池中的异质性与反应细胞发育起源的差异有关。
为了实现这一目标,我们将把我们的新型命运地图系统与特性良好的鼠标相结合
LCMV感染模型来剖析内存池中的功能异质性。我们的初步研究
表明与慢性感染相比,成人来源的细胞优先出现功能衰竭
胎儿来源的细胞。然而,成人来源的CD8+T细胞的克隆性耗竭可以通过以下方法防止
胎儿来源免疫细胞的主要调节因子Lin28b的过表达。基于这些发现和我们的
我们假设CD8+T细胞在慢性感染过程中的命运与它们的
发育起源。在第一个目标中,我们将确定发育起源如何改变CD8+T细胞反应
到慢性病原体。在第二个目标中,我们将研究发育起源如何改变基因调控。
慢性感染时CD8+T细胞中的程序。在最后一个目标中,我们将确定如何发展
Lin28b基因的差异影响CD8+T细胞对慢性感染的反应能力。从以下方面获得的知识
这些研究有望更好地了解CD8+T细胞的调节机制
对慢性病原体的反应,这对于制定更精确和有效的恢复战略至关重要
衰竭的CD8+T细胞的功能。
英文摘要
Project Summary/Abstract
Following infection, a small percentage of effector CD8+ T cells survive and transition into the long-lived memory
pool. Given that memory CD8+ T cells are key to immunity against intracellular pathogens, it is essential that we
understand the mechanisms by which they are formed. This question has been at the forefront of the field for
decades. The current dogma suggests that a single lineage of naïve T cells can give rise to different short- and
long-lived subsets of effector or memory T cells, depending upon the cues (inflammation, antigen) they encounter
during infection. However, in the last funding cycle, we discovered that the propensity for T cells to adopt
particular fates during infection is, instead, pre-programmed prior to infection, and is largely determined by their
developmental origin. As all of our work to date has been performed in the context of acute infections, the major
goal of our renewal proposal is to extend our studies to chronic infection, where we will determine how
heterogeneity within the memory pool is linked to variation in the developmental origins of the responding cells.
To accomplish this goal, we will combine our novel fate mapping system with the well-characterized mouse
model of LCMV infection to dissect the functional heterogeneity within the memory pool. Our preliminary studies
indicate that adult-derived cells preferentially become functionally exhausted during chronic infection compared
to fetal-derived cells. However, clonal exhaustion of adult-derived CD8+ T cells can be prevented by
overexpression of Lin28b, a master regulator of fetal-derived immune cells. Based on these findings and our
published work, we hypothesize that the fate of CD8+ T cells during chronic infection is linked to their
developmental origin. In the first aim, we will determine how developmental origin alters the CD8+ T cell response
to chronic pathogens. In the second aim, we will examine how developmental origin alters gene regulatory
programs in CD8+ T cells during chronic infection. In the last aim, we will determine how developmental
differences in Lin28b influence the ability of CD8+ T cells to respond to chronic infection. Knowledge gained from
these studies is expected to provide a better understanding of the mechanisms regulating the CD8+ T cell
response to chronic pathogens, which is essential for developing more precise and effective strategies to restore
functionality in exhausted CD8+ T cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of CD163L1 in CD8+ T cells
-
批准号:10593557
-
项目类别:
-
资助金额:$23.86万
-
财政年份:2022
-
负责人:ANDREW W GRIMSON
-
依托单位:
MicroRNAs in Tissue-resident memory T cells
-
批准号:10609026
-
项目类别:
-
资助金额:$22.34万
-
财政年份:2022
-
负责人:ANDREW W GRIMSON
-
依托单位:
MicroRNAs in Tissue-resident memory T cells
-
批准号:10354926
-
项目类别:
-
资助金额:$21.48万
-
财政年份:2022
-
负责人:ANDREW W GRIMSON
-
依托单位:
Impact of 3' untranslated region sequence variants in spermiogenic gene expression and infertility
-
批准号:10157201
-
项目类别:
-
资助金额:$56.03万
-
财政年份:2021
-
负责人:ANDREW W GRIMSON
-
依托单位:
Impact of 3' untranslated region sequence variants in spermiogenic gene expression and infertility
-
批准号:10398877
-
项目类别:
-
资助金额:$54.25万
-
财政年份:2021
-
负责人:ANDREW W GRIMSON
-
依托单位:
Impact of 3' untranslated region sequence variants in spermiogenic gene expression and infertility
-
批准号:10615700
-
项目类别:
-
资助金额:$54.31万
-
财政年份:2021
-
负责人:ANDREW W GRIMSON
-
依托单位:
A Single Comprehensive Assay for Gene Regulatory Profiling Optimized for Minimal Sample Input Requirements
-
批准号:10398158
-
项目类别:
-
资助金额:$43.71万
-
财政年份:2020
-
负责人:ANDREW W GRIMSON
-
依托单位:
A Single Comprehensive Assay for Gene Regulatory Profiling Optimized for Minimal Sample Input Requirements
-
批准号:10159213
-
项目类别:
-
资助金额:$43.68万
-
财政年份:2020
-
负责人:ANDREW W GRIMSON
-
依托单位:
Establishing Methods to Delineate 3'UTR-mediated Regulation
-
批准号:10316261
-
项目类别:
-
资助金额:$27.78万
-
财政年份:2020
-
负责人:ANDREW W GRIMSON
-
依托单位:
A Single Comprehensive Assay for Gene Regulatory Profiling Optimized for Minimal Sample Input Requirements
-
批准号:10618150
-
项目类别:
-
资助金额:$43.86万
-
财政年份:2020
-
负责人:ANDREW W GRIMSON
-
依托单位:
Roles for DevelopmentallyRegulated microRNAs in Neonatal Immunity
-
批准号:10221489
-
项目类别:
-
资助金额:$40.02万
-
财政年份:2017
-
负责人:ANDREW W GRIMSON
-
依托单位:
Immune dysfunction in ME/CFS
-
批准号:10627292
-
项目类别:
-
资助金额:$70.47万
-
财政年份:2017
-
负责人:ANDREW W GRIMSON
-
依托单位:
Cornell ME/CFS Collaborative Research Center
-
批准号:10237219
-
项目类别:
-
资助金额:$192.29万
-
财政年份:2017
-
负责人:ANDREW W GRIMSON
-
依托单位:
Roles for DevelopmentallyRegulated microRNAs in Neonatal Immunity
-
批准号:9753926
-
项目类别:
-
资助金额:$34.24万
-
财政年份:2017
-
负责人:ANDREW W GRIMSON
-
依托单位:
Cornell ME/CFS Collaborative Research Center
-
批准号:10627287
-
项目类别:
-
资助金额:$189.64万
-
财政年份:2017
-
负责人:ANDREW W GRIMSON
-
依托单位:
Roles for DevelopmentallyRegulated microRNAs in Neonatal Immunity
-
批准号:9982753
-
项目类别:
-
资助金额:$40.02万
-
财政年份:2017
-
负责人:ANDREW W GRIMSON
-
依托单位:
Deciphering gene dysregulation across the immune system in ME/CFS with single-cell transcriptomics
-
批准号:10237225
-
项目类别:
-
资助金额:$124.48万
-
财政年份:2017
-
负责人:ANDREW W GRIMSON
-
依托单位:
The developmental layers in the CD8+ T cell response to chronic infection
-
批准号:10452556
-
项目类别:
-
资助金额:$47.8万
-
财政年份:2014
-
负责人:ANDREW W GRIMSON
-
依托单位:
The developmental layers in the CD8+ T cell response to chronic infection
-
批准号:10001423
-
项目类别:
-
资助金额:$47.8万
-
财政年份:2014
-
负责人:ANDREW W GRIMSON
-
依托单位:
Identifying cis and trans factors required for microRNA function
-
批准号:8477562
-
项目类别:
-
资助金额:$29.23万
-
财政年份:2013
-
负责人:ANDREW W GRIMSON
-
依托单位:
海外基金